From: Use of palliative radiotherapy in brain and bone metastases (VARA II study)
Bone M | Brain M | |
---|---|---|
Doses (Gy) | ||
Range | (5–44) | (18–32) |
Mean (95%CI) | 22 (21–24) | 23 (21–24) |
Median | 30 | 20 |
Dose fraction: | ||
10 × 300 cGy | 32% | 58% |
5 × 400 cGy | 27% | 20% |
1 × 800 cGy | 25% | 3% |
15 × 200 cGy | 2% | 19% |
3 × 600 cGy | 1% | |
Others | 13% | |
CT planning: | ||
Yes | 88% | 79% |
No | 12% | 21% |
Energy: | ||
Co60 | 43% | 48% |
LA 6 Mv | 13% | 1% |
LA ≥ 15 Mv | 44% | 51% |
Toxicity grade 2-3 | 13% | 15% |